HBVRNA在慢乙肝中临床应用的研究进展
Research Progress in the Clinical Application of HBV RNA in Chronic Hepatitis B
DOI: 10.12677/ACM.2023.131130, PDF,   
作者: 颜 涛*, 易建华#：华中科技大学同济医学院附属协和医院，湖北 武汉
关键词: HBVRNA；慢乙肝；血清标志物；HBVRNA； Chronic Hepatitis B； Serum Marker
摘要: 血清中的HBVRNA是肝细胞内共价环状闭合DNA (covalently closed circular DNA, cccDNA)的直接转录体，其实质是核衣壳内未经转录的前基因组RNA (pregenomic RNA, pgRNA)，转而以病毒颗粒样的方式释放进入血液循环，形成“HBV RNA颗粒”。近年来许多研究表明HBV RNA在监测抗病毒治疗效果、指导停药及预测复发、预测HBeAg血清学转换等方面有重要作用，是慢性乙型病毒性肝炎的一种潜在的新兴病毒学标志物。
Abstract: HBV RNA in serum is a direct transcript of covalently closed circular DNA (cccDNA) in liver cells. Its essence is untranslated pregenomic RNA (pgRNA) in the nucleocapsid, which is released into the blood circulation in a virus particle like manner, forming “HBV RNA particles”. In recent years, many studies have shown that HBV RNA plays an important role in monitoring the effect of antiviral therapy, guiding drug withdrawal, predicting relapse, and predicting HBeAg seroconversion. It is a potential emerging viral marker of chronic hepatitis B.
文章引用：颜涛, 易建华. HBVRNA在慢乙肝中临床应用的研究进展[J]. 临床医学进展, 2023, 13(1): 899-903. https://doi.org/10.12677/ACM.2023.131130

参考文献

[1] Wu, Y., Wen, J., Xiao, W. and Zhang, B. (2019) Pregenomic RNA: How to Assist the Management of Chronic Hepatitis B? Reviews in Medical Virology, 29, e2051. [Google Scholar] [CrossRef] [PubMed]
[2] Valery, P.C., Laversanne, M., Clark, P.J., Petrick, J.L., McGlynn, K.A. and Bray, F. (2018) Projections of Primary Liver Cancer to 2030 in 30 Coun-tries Worldwide. Hepatology, 67, 600-611. [Google Scholar] [CrossRef] [PubMed]
[3] Lucifora, J., Xia, Y., Reisinger, F., Zhang, K., Stadler, D., Cheng, X., et al. (2014) Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Vi-rus cccDNA. Science, 343, 1221-1228. [Google Scholar] [CrossRef] [PubMed]
[4] Wang, J., Xu, Z.W., Liu, S., Zhang, R.Y., Ding, S.L., Xie, X.M., et al. (2015) Dual gRNAs Guided CRISPR/Cas9 System Inhibits Hepatitis B Virus Replication. World Journal of Gastroenterology, 21, 9554-9565. [Google Scholar] [CrossRef] [PubMed]
[5] Hong, X., Kim, E.S. and Guo, H. (2017) Epigenetic Regulation of Hepatitis B Virus Covalently Closed Circular DNA: Implications for Epigenetic Therapy against Chronic Hepatitis B. Hepatology, 66, 2066-2077. [Google Scholar] [CrossRef] [PubMed]
[6] Sun, S., Nakashima, K., Ito, M., Li, Y., Chida, T., Takahashi, H., et al. (2017) Involvement of PUF60 in Transcriptional and Post-Transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression. Scientific Reports, 7, Article No. 12874. [Google Scholar] [CrossRef] [PubMed]
[7] Diogo Dias, J., Sarica, N. and Neuveut, C. (2021) Early Steps of Hepatitis B Life Cycle: From Capsid Nuclear Import to cccDNA Formation. Viruses, 13, Article No. 757. [Google Scholar] [CrossRef] [PubMed]
[8] Kojabad, A.A., Farzanehpour, M., Galeh, H.E.G., Dorostkar, R., Jafarpour, A., Bolandian, M., et al. (2021) Droplet Digital PCR of Viral DNA/RNA, Current Progress, Challenges, and Future Perspectives. Journal of Medical Virology, 93, 4182-4197. [Google Scholar] [CrossRef] [PubMed]
[9] Limothai, U., Chuaypen, N., Poovorawan, K., Chotiyaputta, W., Tanwandee, T., Poovorawan, Y., et al. (2020) Reverse Transcriptase Droplet Digital PCR vs Reverse Transcriptase Quantitative Real-Time PCR for Serum HBV RNA Quantification. Jour-nal of Medical Virology, 92, 3365-3372. [Google Scholar] [CrossRef] [PubMed]
[10] Jansen, L., Kootstra, N.A., van Dort, K.A., Takkenberg, R.B., Reesink, H.W. and Zaaijer, H.L. (2016) Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues. The Journal of Infectious Diseases, 213, 224-232. [Google Scholar] [CrossRef] [PubMed]
[11] van Bömmel, F., Bartens, A., Mysickova, A., Hofmann, J., Krüger, D.H., Berg, T. and Edelmann, A. (2015) Serum Hepatitis B Virus RNA Levels as an Early Predictor of Hepatitis B Envelope Antigen Seroconversion during Treatment with Polymerase Inhibitors. Hepatology, 61, 66-76. [Google Scholar] [CrossRef] [PubMed]
[12] van Bömmel, F., van Bömmel, A., Krauel, A., Wat, C., Pavlovic, V., Yang, L., et al. (2018) Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B. The Journal of Infectious Diseases, 218, 1066-1074. [Google Scholar] [CrossRef] [PubMed]
[13] Huang, Y.-W., Takahashi, S., Tsuge, M., Chen, C.-L., Wang, T.-C., Abe, H., et al. (2015) On-Treatment Low Serum HBV RNA Level Predicts Initial Virological Response in Chronic Hepatitis B Patients Receiving Nucleoside Analogue Therapy. Antiviral Therapy, 20, 369-375. [Google Scholar] [CrossRef] 
[14] Pan, J., Xu, J., Luo, H., Tan, N., Kang, Q., Chen, H., et al. (2021) Factors and Virological Significance of Hepatitis B Virus Pregenomic RNA Status after 5 Years of Antiviral Therapy. Interna-tional Journal of Infectious Diseases, 105, 418-423. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, Y., Liu, Y., Liao, H., Deng, Z., Bian, D., Ren, Y., et al. (2022) Serum HBV DNA plus RNA Reflecting cccDNA Level before and during NAs Treatment in HBeAg Positive CHB Patients. International Journal of Medical Sciences, 19, 858-866. [Google Scholar] [CrossRef] [PubMed]
[16] Lin, N., Ye, A., Lin, J., Liu, C., Huang, J., Fu, Y., et al. (2020) Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes. Journal of Clinical Microbiology, 58. [Google Scholar] [CrossRef] 
[17] Wang, J., Shen, T., Huang, X., Kumar, G.R., Chen, X., Zeng, Z., et al. (2016) Serum Hepatitis B Virus RNA Is Encapsidated Pregenome RNA That May Be Associated with Persistence of Viral Infection and Rebound. Journal of Hepatology, 65, 700-710. [Google Scholar] [CrossRef] [PubMed]
[18] Fan, R., Zhou, B., Xu, M., Tan, D., Niu, J., Wang, H., et al. (2020) Association between Negative Results from Tests for HBV DNA and RNA and Durability of Response after Discontin-uation of Nucles(t)ide Analogue Therapy. Clinical Gastroenterology and Hepatology, 18, 719-727. [Google Scholar] [CrossRef] [PubMed]
[19] He, J.Z., Xu, Y.F. and Lei, X.Z. (2022) [Clinical Significance of Hepatitis B Virus pgRNA for Deciding Antiviral Therapy Discontinuation in Patients with Chronic Hepatitis B]. Chinese Journal of Hepatology, 30, 970-975. (In Chinese)
[20] Luo, H., Tan, N., Kang, Q., Pan, J., Chen, H., Xi, H., et al. (2020) Hepatitis B Virus Pregenomic RNA Status Can Reveal the Long-Term Prognoses of Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogues. Journal of Viral Hepatitis, 27, 323-328. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, M.-L., Liao, J., Ye, F., Tao, Y.-C., Wu, D.-B., He, M., et al. (2021) Distribution and Factors Associated with Serum HBV Pregenomic RNA Levels in Chinese Chronic Hepatitis B Patients. Journal of Medical Virology, 93, 3688-3696. [Google Scholar] [CrossRef] [PubMed]
[22] Tao, Y., Wang, M., Liao, J., Cheng, X., He, M., Zhang, D., et al. (2022) Dynamics of Serum Pregenome RNA in Chronic Hepatitis B Patients Re-ceiving 96-Month Nucleos(t)ide Analog Therapy. Frontiers in Medicine, 9, Article ID: 787770. [Google Scholar] [CrossRef] [PubMed]
[23] Wu, Y., Wen, J., Tang, G., Zhang, J. and Xin, J. (2021) On-Treatment HBV RNA Dynamic Predicts Entecavir-Induced HBeAg Seroconversion in Children with Chronic Hepa-titis B. The Journal of Infection, 83, 594-600. [Google Scholar] [CrossRef] [PubMed]

为你推荐